gls-5700
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2016 (NCT02809443)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Zika virusImmunity, active
immunity, active - zika virus
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gls-5700
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02887482 | Phase 1 | Aug 1, 2016 | GeneOne Life Science, Inovio Pharmaceuticals |
| NCT02809443 | Phase 1 | Jul 1, 2016 | GeneOne Life Science, Inovio Pharmaceuticals |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GeneOne Life Science | For profit | 2 | 2 | 1 | 2016 |
| Inovio Pharmaceuticals | For profit | 2 | 0 | 1 | 2016 |
2 organizations
Page 1 / 1